The story of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, generating billions in revenue , its exclusivity period created a flood of generic https://singnalsocial.com/story6413107/copyright-s-pill-and-big-pharma-a-uncertain-investment